IGM Biosciences Inc (IGMS)
1.24
-0.04
(-3.12%)
USD |
NASDAQ |
Mar 28, 16:00
1.24
0.00 (0.00%)
After-Hours: 20:00
IGM Biosciences Shareholders Equity (Quarterly): 48.17M for Dec. 31, 2024
View 4,000+ Financial Data Types:
Add
Browse
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| BioXcel Therapeutics Inc | -85.63M |
| Biomea Fusion Inc | 75.97M |
| NovaBay Pharmaceuticals Inc | 1.072M |
| Palatin Technologies Inc | -6.381M |
| Theriva Biologics Inc | 19.07M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 265.71M |
| Total Liabilities (Quarterly) | 217.54M |
| Current Ratio | 5.144 |